跳至主要内容
临床试验/CTRI/2023/08/056963
CTRI/2023/08/056963尚未招募3 期

Randomised controlled clinical trial to compare the efficacy of dhatryadi kwath and vasadi kwath in management of vatarakta. - Nil

Vd Ravindra Namdev Sagbhor0 个研究点目标入组 0 人开始时间: 待定最近更新:

试验速览

阶段
3 期
状态
尚未招募
发起方

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

入选标准

  • 1.Patient having signs and symptoms of vatarakta like shotha,kathinya,vedanadhikya,daha,Tod,shyavata/tamrata,spuran.
  • Patient of any sex, religion and socio-economic status.
  • 2.newly diagnosed patient.
  • 3.Patient with serum uric acid >7mg/dl in male and 6mg/dl in female.

排除标准

  • 1.Pathophysiology or genetic syndrome associated with vatarakta.
  • 2.patient in serious symptoms like paak,khanja,pangulya and sandhivakrata are excluded.
  • 3 malignancy, poorly controlled DM,HTN.
  • 4.symptomatic patient with clinical evidence of heart failure.
  • 5.complicated patient having target organ damage.
  • 6.alcoholic and drug abusers, pregnant and lactating women.

研究者

发起方
Vd Ravindra Namdev Sagbhor

相似试验